NYSE · Stock
ABBV
AbbVie Inc.
257.42
Market closed · last price 15h ago
Last 24 hours
Bid
257.34
Ask
257.50
Day High
259.27
Day Low
255.72
ABBV key statistics
1 week
-0.25%
1 month
-3.17%
52w high
266.94
52w low
195.42
Avg daily range
+1.50%
History from
13 Aug 2025
Highs and lows are taken from 261 daily bars — the high was set on 28 Jul 2026 and the low on 29 Apr 2026. ABBV is quoted to 5 decimal places, minimum tick 0.00001, spread at last quote 0.16000, quoted in USD on NYSE, sourced from MetaTrader 5 (Broker 1).
ABBV daily history
| Date | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| 11 Sept 2026 | 258.32 | 259.48 | 255.86 | 257.33 | -0.38% |
| 09 Sept 2026 | 248.64 | 250.90 | 248.39 | 250.55 | +0.77% |
| 08 Sept 2026 | 252.60 | 254.54 | 249.28 | 249.42 | -1.26% |
| 04 Sept 2026 | 258.13 | 258.76 | 255.77 | 256.21 | -0.74% |
| 01 Sept 2026 | 261.32 | 261.81 | 257.88 | 259.08 | -0.86% |
| 31 Aug 2026 | 254.73 | 258.22 | 253.54 | 257.98 | +1.28% |
| 28 Aug 2026 | 257.09 | 257.96 | 255.13 | 255.84 | -0.48% |
| 27 Aug 2026 | 259.54 | 259.91 | 257.47 | 258.33 | -0.47% |
| 26 Aug 2026 | 263.37 | 263.47 | 260.40 | 262.72 | -0.25% |
| 20 Aug 2026 | 264.51 | 265.87 | 260.48 | 261.12 | -1.28% |
ABBV API access
AbbVie Inc. prices are available over REST and WebSocket with no API key and no signup. Rate limit is 15,000 requests per minute per IP.
curl
curl "https://biquote.io/api/ABBV"
Python
import requests
r = requests.get("https://biquote.io/api/ABBV")
tick = r.json()
print(tick["mid"], tick["dayDiffPercent"])JavaScript
const r = await fetch("https://biquote.io/api/ABBV");
const tick = await r.json();
console.log(tick.mid, tick.dayDiffPercent);WebSocket
// SignalR hub — pushes every tick for ABBV
const conn = new signalR.HubConnectionBuilder()
.withUrl("https://biquote.io/hubs/tick")
.build();
conn.on("ReceiveTick", t => console.log(t.symbol, t.mid));
await conn.start();
await conn.invoke("Subscribe", "ABBV");Also available for ABBV: daily candles, hourly candles · full API documentation
News about ABBV
- Is AbbVie (ABBV)’s $10.9 Billion Apogee Therapeutics (APGE) Deal the Next Catalyst for Growth?Yahoo Finance·2d ago
- Is AbbVie Stock Actually Overpriced?trefis.com·16h ago
- AbbVie's ABBV-1480 Posts 90% Response Rate in Frontline NSCLC CombinationBioPharm International·3w ago
- AbbVie (ABBV) Posted Positive Phase 3 Results For Menstrual Migraine Preventionsimplywall.st·1d ago
- SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trialNature·14w ago
- ABBV: Strong immunology growth and innovative oncology assets set the stage for long-term expansionTradingView·2d ago